These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20429798)

  • 1. Association of the SLC22A1, SLC22A2, and SLC22A3 genes encoding organic cation transporters with diabetic nephropathy and hypertension.
    Sallinen R; Kaunisto MA; Forsblom C; Thomas M; Fagerudd J; Pettersson-Fernholm K; Groop PH; Wessman M;
    Ann Med; 2010 May; 42(4):296-304. PubMed ID: 20429798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.
    Zhang D; Ma J; Brismar K; Efendic S; Gu HF
    J Diabetes Complications; 2009; 23(4):265-72. PubMed ID: 18599322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy.
    Möllsten A; Wessman M; Svensson M; Forsblom C; Parkkonen M; Brismar K; Groop PH; Dahlquist G
    Ann Med; 2006; 38(7):522-8. PubMed ID: 17101543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder.
    Aoyama N; Takahashi N; Kitaichi K; Ishihara R; Saito S; Maeno N; Ji X; Takagi K; Sekine Y; Iyo M; Harano M; Komiyama T; Yamada M; Sora I; Ujike H; Iwata N; Inada T; Ozaki N
    Alcohol Clin Exp Res; 2006 Oct; 30(10):1644-9. PubMed ID: 17010131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning of the mouse and human solute carrier 22a3 (Slc22a3/SLC22A3) identifies a conserved cluster of three organic cation transporters on mouse chromosome 17 and human 6q26-q27.
    Verhaagh S; Schweifer N; Barlow DP; Zwart R
    Genomics; 1999 Jan; 55(2):209-18. PubMed ID: 9933568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. The Diabetic Nephropathy Study Group.
    Schmidt S; Giessel R; Bergis KH; Strojek K; Grzeszczak W; Ganten D; Ritz E
    Nephrol Dial Transplant; 1996 Sep; 11(9):1755-61. PubMed ID: 8918618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy.
    McKnight AJ; Savage DA; Patterson CC; Sadlier D; Maxwell AP
    BMC Med Genet; 2007 Feb; 8():5. PubMed ID: 17319955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma.
    Lautem A; Heise M; Gräsel A; Hoppe-Lotichius M; Weiler N; Foltys D; Knapstein J; Schattenberg JM; Schad A; Zimmermann A; Otto G; Lang H; Galle PR; Schuchmann M; Zimmermann T
    Int J Oncol; 2013 Apr; 42(4):1297-304. PubMed ID: 23440379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD2AP is associated with end-stage renal disease in patients with type 1 diabetes.
    Hyvönen ME; Ihalmo P; Sandholm N; Stavarachi M; Forsblom C; McKnight AJ; Lajer M; Maestroni A; Lewis G; Tarnow L; Maestroni S; Zerbini G; Parving HH; Maxwell AP; Groop PH; Lehtonen S
    Acta Diabetol; 2013 Dec; 50(6):887-97. PubMed ID: 23681557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.
    Mtiraoui N; Ezzidi I; Chaieb M; Marmouche H; Aouni Z; Chaieb A; Mahjoub T; Vaxillaire M; Almawi WY
    Diabetes Res Clin Pract; 2007 Jan; 75(1):99-106. PubMed ID: 16828193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis.
    Palmieri O; Latiano A; Valvano R; D'Incà R; Vecchi M; Sturniolo GC; Saibeni S; Peyvandi F; Bossa F; Zagaria C; Andriulli A; Devoto M; Annese V
    Aliment Pharmacol Ther; 2006 Feb; 23(4):497-506. PubMed ID: 16441470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3).
    Bourdet DL; Pritchard JB; Thakker DR
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1288-97. PubMed ID: 16141367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible association of SLC22A2 polymorphisms with aspirin-intolerant asthma.
    Park TJ; Kim JH; Bae JS; Park BL; Cheong HS; Chun JY; Lee JS; Kim JY; Pasaje CF; Cho SH; Uh ST; Kim MK; Choi IS; Koh IS; Park CS; Shin HD
    Int Arch Allergy Immunol; 2011; 155(4):395-402. PubMed ID: 21346370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal tumours in a Tsc1+/- mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin.
    Yang J; Kalogerou M; Gallacher J; Sampson JR; Shen MH
    Eur J Cancer; 2013 Apr; 49(6):1479-90. PubMed ID: 23228442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: a case control study.
    Santiago JL; Martínez A; de la Calle H; Fernández-Arquero M; Figueredo MA; de la Concha EG; Urcelay E
    BMC Med Genet; 2006 Jun; 7():54. PubMed ID: 16796743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM Complications Study.
    Roglic G; Colhoun HM; Stevens LK; Lemkes HH; Manes C; Fuller JH
    Diabet Med; 1998 May; 15(5):418-26. PubMed ID: 9609365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance.
    Heise M; Lautem A; Knapstein J; Schattenberg JM; Hoppe-Lotichius M; Foltys D; Weiler N; Zimmermann A; Schad A; Gründemann D; Otto G; Galle PR; Schuchmann M; Zimmermann T
    BMC Cancer; 2012 Mar; 12():109. PubMed ID: 22439694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of alpha-adducin DNA polymorphisms in the genetic predisposition to diabetic nephropathy.
    Conway BR; Martin R; McKnight AJ; Savage DA; Brady HR; Maxwell AP
    Nephrol Dial Transplant; 2004 Aug; 19(8):2019-24. PubMed ID: 15187197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
    Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
    Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of VEGF-1499C-->T polymorphism with diabetic nephropathy in type 1 diabetes mellitus.
    McKnight AJ; Maxwell AP; Patterson CC; Brady HR; Savage DA
    J Diabetes Complications; 2007; 21(4):242-5. PubMed ID: 17616354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.